We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIVE icon
301
Five Below
FIVE
$11.7B
$8.45M 0.06%
47,790
+39,868
+503% +$7.94M
APLS
302
DELISTED
Apellis Pharmaceuticals
APLS
$8.4M 0.06%
255,030
-62,285
-20% -$3.5M
HAS icon
303
Hasbro
HAS
$13.6B
$8.4M 0.06%
94,153
+8,571
+10% +$832K
TWTR
304
DELISTED
Twitter, Inc.
TWTR
$8.32M 0.06%
46,622
+749
+2% +$49.2K
ECHO
305
DELISTED
Echo Global Logistics, Inc.
ECHO
$8.31M 0.06%
+140,098
New +$4.84M
SAGE
306
DELISTED
Sage Therapeutics
SAGE
$8.2M 0.06%
185,058
+46,490
+34% +$2.13M
PH icon
307
Parker-Hannifin
PH
$120B
$8.16M 0.06%
29,168
-43,435
-60% -$12.9M
ZGNX
308
DELISTED
Zogenix, Inc.
ZGNX
$8.15M 0.06%
536,758
– –
RIGL icon
309
Rigel Pharmaceuticals
RIGL
$730M
$8.06M 0.05%
222,170
– –
WAB icon
310
Wabtec
WAB
$49.7B
$8.04M 0.05%
93,274
+67,343
+260% +$5.8M
CAI
311
DELISTED
CAI International, Inc.
CAI
$8.01M 0.05%
+143,192
New +$8M
KR icon
312
Kroger
KR
$36.6B
$8M 0.05%
197,906
-261,568
-57% -$11M
DRNA
313
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7.93M 0.05%
393,390
-24,855
-6% -$686K
MSI icon
314
Motorola Solutions
MSI
$72.1B
$7.89M 0.05%
33,979
+22,887
+206% +$5.31M
NBIX icon
315
Neurocrine Biosciences
NBIX
$18.3B
$7.82M 0.05%
81,513
+20
+0% +$1.89K
TWST icon
316
Twist Bioscience
TWST
$5.38B
$7.79M 0.05%
72,841
– –
LMRK
317
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$7.74M 0.05%
+473,397
New +$7M
LYFT icon
318
Lyft
LYFT
$5.91B
$7.7M 0.05%
143,732
+133,960
+1,371% +$7.1M
CSX icon
319
CSX Corp
CSX
$94.1B
$7.42M 0.05%
249,673
-7,676
-3% -$246K
IEX icon
320
IDEX
IEX
$17B
$7.42M 0.05%
35,839
-4,295
-11% -$953K
TD icon
321
Toronto Dominion Bank
TD
$194B
$7.39M 0.05%
111,730
-18,395
-14% -$1.23M
DDOG icon
322
Datadog
DDOG
$95.9B
$7.36M 0.05%
52,047
+40,087
+335% +$5.06M
DTIL icon
323
Precision BioSciences
DTIL
$176M
$7.31M 0.05%
21,105
– –
CI icon
324
Cigna
CI
$78.7B
$7.23M 0.05%
36,120
-1,674
-4% -$364K
COF icon
325
Capital One
COF
$128B
$7.19M 0.05%
44,368
+3,190
+8% +$521K
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.